Home › Funds › Palo Alto Investors LP › RARE
Palo Alto Investors LP position in RARE
ULTRAGENYX PHARMACEUTICAL IN · Health Care
Palo Alto Investors LP reported holding 710,029 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN) in its Q3 2026 13F filing — a position valued at US$10.7M, representing 1.59% of its reported portfolio and ranking #19 among its reported holdings. Palo Alto Investors LP has disclosed RARE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's RARE position evolved
Palo Alto Investors LP first disclosed a stake in RARE in Q2 2025 at 48,750 shares (US$1.8M). The position peaked in Q2 2026 at 596,495 shares, worth US$19.9M. Across 6 filings, Palo Alto Investors LP increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 710,029 shares valued at US$10.7M — an increase of 113,534 shares quarter over quarter.. Notable position changes include a 658% increase in Q3 2025 (shares fell 24% over the following quarter), a 29% increase in Q1 2026 (shares rose 59% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 48.75K | $1.77M | New |
| Q3 2025 | 369.53K | $11.12M | Add |
| Q4 2025 | 461.29K | $10.61M | Add |
| Q1 2026 | 596.50K | $12.50M | Add |
| Q2 2026 | 596.50K | $19.92M | Hold |
| Q3 2026 | 710.03K | $10.67M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RARE and 13F data
RARE (ULTRAGENYX PHARMACEUTICAL IN) is a Health Care company. 14 other funds we track also report a position in RARE — the largest reported positions include RTW INVESTMENTS, LP (US$128.2M), Nantahala Capital Management, LLC (US$35.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RARE
- RTW INVESTMENTS, LP 8.53M sh · $128.20M · Q3 2026
- Nantahala Capital Management, LLC 2.34M sh · $35.16M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held RARE?
Palo Alto Investors LP has disclosed RARE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Palo Alto Investors LP's current position in RARE?
As of Q3 2026, Palo Alto Investors LP holds 710.03K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $10.67M, representing 1.59% of its reported portfolio and ranking #19.
Has Palo Alto Investors LP been buying or selling RARE?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP increased its position in RARE. The position peaked in Q2 2026 at 596.50K shares.
Which other funds hold RARE?
Other major institutional holders of RARE include RTW INVESTMENTS, LP, Nantahala Capital Management, LLC, among 14 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.